.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Deloitte
Accenture
Federal Trade Commission
Medtronic
QuintilesIMS
Teva
Farmers Insurance
Boehringer Ingelheim
Moodys

Generated: July 23, 2017

DrugPatentWatch Database Preview

METHYLIN ER Drug Profile

« Back to Dashboard

Which patents cover Methylin Er, and when can generic versions of Methylin Er launch?

Methylin Er is a drug marketed by Mallinckrodt Inc and is included in one NDA.

The generic ingredient in METHYLIN ER is methylphenidate hydrochloride. There are thirty-one drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

Summary for Tradename: METHYLIN ER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list43
Patent Applications: see list2,393
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHYLIN ER at DailyMed

Pharmacology for Tradename: METHYLIN ER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Inc
METHYLIN ER
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE;ORAL075629-001May 9, 2000ABRXNoNo► Subscribe► Subscribe
Mallinckrodt Inc
METHYLIN ER
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE;ORAL075629-002May 9, 2000ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
McKinsey
Chinese Patent Office
US Department of Justice
Fish and Richardson
Julphar
Argus Health
Boehringer Ingelheim
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot